EDAP’s HIFU Progress Is Obscured By The Pandemic, But It’s Real

  • Favorable changes in market acceptance and reimbursement for the FocalOne have been obscured by pandemic headwinds.
  • However, the company continues at breakeven because of strong growth in its distribution business, the result of a fantastic strategic deal with Exact Imaging.
  • While pandemic headwinds could blow a little longer, sooner or later the lid will be blown off of FocalOne installation growth and as long as the distribution business.
  • As long as the distribution business keeps on delivering, the wait isn’t problematic and the shares are already attractive at $6 and change.
  • Learn More »